Retrieve available abstracts of 23 articles: HTML format
Single Articles
May 2025
LI J, Chen R, Zhao X, Liu C, et al Circulating and Regional Matrix Gla Protein Indicating Plaque Calcification and
Prognosis of Patients with ST-Segment Elevation Myocardial Infarction.
Thromb Haemost. 2025 May 23. doi: 10.1055/a-2599-9386. PubMedAbstract available
April 2025
SPAGNOLO M, Capodanno D Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic
Protection?
Thromb Haemost. 2025 Apr 25. doi: 10.1055/a-2593-1763. PubMedAbstract available
VALERIANI E, Sesso HD, Pastori D, Menichelli D, et al Age related clinical efficacy of aspirin for primary cardiovascular prevention: a
systematic-review and meta-analysis.
Thromb Haemost. 2025 Apr 11. doi: 10.1055/a-2580-6931. PubMedAbstract available
March 2025
GOROG DA, Jeong YH Factor XI Measurement in Acute Coronary Syndrome.
Thromb Haemost. 2025 Mar 31. doi: 10.1055/a-2546-2581. PubMed
February 2025
DUAN Y, Qiu M, Na K, Liu D, et al Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome
Patients Undergoing Percutaneous Coronary Intervention.
Thromb Haemost. 2025 Feb 4. doi: 10.1055/a-2531-3268. PubMedAbstract available
ZHENG YY, Wu TT, Hou XG, Yang Y, et al Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who
Underwent PCI: Findings from the PRACTICE Study.
Thromb Haemost. 2025;125:178-187. PubMedAbstract available
January 2025
SPAGNOLO M, Ammirabile N, Cutore L, Di Leo G, et al Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment
Elevation Myocardial Infarction Undergoing Primary PCI.
Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2525-4219. PubMedAbstract available
December 2024
JANG JY, Ga-In Y, Jongwha A, Bae JS, et al Optimal Long-term Antiplatelet Regimen for Patients with High Ischaemic and
Bleeding Risks After Percutaneous Coronary Intervention.
Thromb Haemost. 2024 Dec 10. doi: 10.1055/a-2499-5458. PubMedAbstract available
November 2024
SUAREZ A, Tobio-Parada U, Rodriguez-Carrio J, Martinez-Zapico A, et al Circulating levels of Low Density Granulocytes and cell-free DNA as predictors of
cardiovascular disease and bone deterioration in SLE patients.
Thromb Haemost. 2024 Nov 14. doi: 10.1055/a-2467-6826. PubMedAbstract available
GU M, Xia N, Zhang S, Zhu X, et al Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment
Elevation Myocardial Infarction.
Thromb Haemost. 2024 Nov 7. doi: 10.1055/a-2437-6111. PubMedAbstract available
October 2024
VAN DER SANGEN NMR, Azzahhafi J, Chan Pin Yin DRPP, Zaaijer LJG, et al Treatment Modifications in Acute Coronary Syndrome Patients Treated with
Ticagrelor: Insights from the FORCE-ACS Registry.
Thromb Haemost. 2024 Oct 29. doi: 10.1055/a-2421-8866. PubMedAbstract available
GRAGNANO F, Angiolillo D Ticagrelor therapy modifications after acute coronary syndrome: An ever-evolving
issue.
Thromb Haemost. 2024 Oct 24. doi: 10.1055/a-2448-7029. PubMedAbstract available
ASARE Y, Simsekyilmaz S, Kohncke J, Shagdarsuren G, et al Cardiac repair after myocardial infarction is controlled by a complement C5a
receptor 1-driven signaling cascade.
Thromb Haemost. 2024 Oct 4. doi: 10.1055/a-2434-4905. PubMedAbstract available
September 2024
GEISLER T Editorial : "Clinical impact of dyspnea after ticagrelor treatment and the effect
of switching to clopidogrel in patients with myocardial infarction".
Thromb Haemost. 2024 Sep 23. doi: 10.1055/a-2420-0381. PubMedAbstract available
August 2024
KONSTANTINIDES SV Shifting Priorities in the Prevention of Venous Thromboembolism: Time to Focus on
Overall Cardiovascular Health.
Thromb Haemost. 2024 Aug 12. doi: 10.1055/s-0044-1788926. PubMed
June 2024
HRISTOV M, Weber C Monocyte subsets in cardiovascular disease: a biomarker perspective.
Thromb Haemost. 2024 Jun 19. doi: 10.1055/a-2348-5697. PubMedAbstract available
CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary
Intervention.
Thromb Haemost. 2024;124:595-597. PubMed
UEKI Y, Haner JD, Losdat S, Gargiulo G, et al Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and
Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
Thromb Haemost. 2024;124:517-527. PubMedAbstract available
May 2024
BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews
with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
Thromb Haemost. 2024;124:482-496. PubMedAbstract available
April 2024
LIANG B, Zha L, Peng B, Chen Q, et al Association of Cardiovascular Health with the Incidence of Venous
Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631. PubMedAbstract available
KIM SH, Shin S, Choo EH, Choi IJ, et al Clinical impact of dyspnoea after ticagrelor treatment and the effect of
switching to clopidogrel in patients with myocardial infarction.
Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4537. PubMedAbstract available
March 2024
ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to
Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The
Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thromb Haemost. 2024;124:263-273. PubMedAbstract available
December 2023
YE Y, Hao Y, Zhao X, Liu J, et al Percutaneous coronary intervention in acute coronary syndrome with
mild-to-moderate thrombocytopenia.
Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263. PubMedAbstract available